Eva Grant, DO
Family Medicine · Tampa, FLNPI 1275817512
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,015 of the $1,589 with a category attached, or 63.9%. Genentech, Inc. accounts for 63.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $1,193 and has fallen 98.9% since, to $13 in 2025.
Across 36 payments — averaging $44.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1K
- Genentech USA, Inc.$238
- Molnlycke Health Care US, LLC$43
- Novo Nordisk$43
- Hologic Sales And Service, LLC$41
- Bioventus LLC$36
- plus $173 from 8 others
What the payments were for
- Consulting fees$1,01564%
- Food & beverage$57436%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 1 | $1,015 |
| Genentech USA, Inc. | 17 | $238 |
| Molnlycke Health Care US, LLC | 2 | $43 |
| Novo Nordisk | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Bioventus LLC | 2 | $36 |
| Orthofix Medical, Inc. | 2 | $35 |
| Heraeus Medical, LLC. | 2 | $29 |
| AbbVie | 1 | $28 |
| KCI USA, Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $18 |
| AstraZeneca | 1 | $15 |
| Penumbra, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xofluza$1,015
How this compares
$1,589 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $222 |
| Doxycycline Monohydrate | 18 | $201 |
| Fluticasone Propionate | 28 | $185 |
| Prednisone | 59 | $177 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $166 |
| Fluconazole | 19 | $99 |
| Azithromycin | 25 | $93 |
| Ciprofloxacin Hcl | 13 | $79 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tampa
- Emily HornTampa$184K
- Mark SeldesTampa$36K
- Robert MirskyTampa$31K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.